Loading paragraph...
Today's Biggest Stock Gainers
Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
---|---|---|---|---|---|---|---|
ELBM | Electra Battery Materials Corporation | $2.37 | $0.73 | 44.46% | - | - | - |
KZR | Kezar Life Sciences | $5.88 | $1.71 | 0.41% | 2.3M | $30.5M | $3.53$8.45 |
VHC | VirnetX | $27.36 | $10.36 | 0.61% | 1.2M | $72.6M | $3.68$29 |
ACHV | Achieve Life Sciences | $4.09 | $1.01 | 0.33% | 4.3M | $157.4M | $1.84$5.31 |
IRON | Disc Medicine | $94.76 | $20.4 | 0.27% | 33.5K | $2.6B | $30.82$95.6 |
SGBX | Safe & Green | $4.03 | $0.95 | 0.31% | 15.9M | $1.5M | $3$122.88 |
SGHT | Sight Sciences | $4.3 | $0.85 | 0.25% | 5.5K | $180.7M | $2.03$6.08 |
CREV | Carbon Revolution Public Limited Ordinary Shares | $4.6 | $0.88 | 23.49% | - | - | - |
SDA | SunCar Technology Group | $2.29 | $0.39 | 0.21% | 3.7K | $195.0M | $1.87$11.28 |
REKR | Rekor Systems | $2.82 | $0.22 | 0.08% | 3.8M | $328.5M | $0.62$2.99 |
Related Articles
Featured Article
These 2 Stocks Soared by Double-Digit Percentages on Wednesday
Dan Caplinger|Jun 14, 2023
The Fed's pause didn't do much for broader stock markets, but it also didn't eat into the gains for these two companies.

3 Stocks That Have Soared as the Market Sank: Are They Buys Now?
Keith Speights|Jan 28, 2022
Two of them could be.

Here's What Investors Need to Know About Sight Sciences Stock
Rachel Warren and Asit Sharma|Jan 12, 2022
The company is a newer player in the medical devices space.

Should Investors Consider Sight Sciences Stock?
Rachel Warren, Jason Hall, and Asit Sharma|Jan 10, 2022
The company recently became publicly traded.

This 2020 Biotech IPO Is Poised to Break Out in 2021
Patrick Bafuma|Apr 2, 2021
Revolution Medicines' leading compound is shaping up to be a platform in a pill.

VirnetX Beats Apple Again in Decade-Old Patent Lawsuit
Rich Duprey|Sep 2, 2020
The long-running court battle may be finally drawing to a close, with Apple having to pay almost $440 million.

Is This Flaming Hot Biotech Stock a Buy?
Zhiyuan Sun|Jun 9, 2020
Kezar Life Sciences just released interim results on its only drug and shares jumped 70%. Now that the stock has settled, is it a good time to buy?

Why These Gas Stocks Plummeted More Than 20% in March
John Bromels|Apr 9, 2020
Natural gas isn't oil, but market uncertainty threw a wrench into their plans anyway.

Better Buy: Tellurian vs. NextDecade
John Bromels|Mar 15, 2020
Shares of both these top LNG startups have had a horrible 2020. Which is more likely to turn things around?

Why 2019's Losses Don't Mean Much for Tellurian and NextDecade
John Bromels|Mar 9, 2020
These two companies aspire to be top LNG exporters. Today's results don't shed much light on their odds.
